Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Thrombosis and Haemostasis : JTH|May 8, 2025
von Willebrand disease-specific defects and proteomic signatures in endothelial colony-forming cellsSebastiaan N J Laan, Stijn Groten, Richard J Dirven, et al.Thrombosis Research|March 10, 2024
Impact of allele-selective silencing of von Willebrand factor in mice based on a single nucleotide allelic difference in von Willebrand factorYvonne K Jongejan, Noa A Linthorst, Elisa Schrader Echeverri, et al.Research and Practice in Thrombosis and Haemostasis|March 17, 2025
Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic miceYvonne K Jongejan, Richard J Dirven, Elisa Schrader Echeverri, et al.Blood Advances|July 19, 2023
Small interfering RNA-mediated allele-selective silencing of von Willebrand factor in vitro and in vivoYvonne K Jongejan, Elisa Schrader Echeverri, Richard J Dirven, et al.Cells|September 13, 2025
Heart Failure Impacts Endothelial Cell Responses to Cardiac Surgery on Cardiopulmonary BypassOlga Papazisi, Rudmer J Postma, Richard J Dirven, et al.Journal of Thrombosis and Haemostasis : JTH|March 6, 2026
Advancing precision diagnostics in coagulation: introduction and analytical validation of a multiplex mass spectrometry-based test for five coagulation factorsNoa A Linthorst, Richard J Dirven, Fred P H T M Romijn, et al.Blood Advances|July 2, 2020
Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanismsAshley Cartwright, Simon J Webster, Annika de Jong, et al.Blood Advances|January 17, 2025
Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAsNoa A Linthorst, Yvonne K Jongejan, Richard J Dirven, et al.Pageof 2